Skip to main content
SpringerLink
Log in

Cancer Rehabilitation

  • Chapter
  • First Online:
Essentials of Interventional Cancer Pain Management

Abstract

Cancer rehabilitation encompasses the treatment of physical and functional limitations due to the clinical course of cancer and its therapeutic toxicities. Cancer’s disabling constitution is multifactorial owing to direct exacerbation of medical comorbidities potentiated by malignant progression and side effects of pain management, chemotherapy, and radiation. Efficacious cancer rehabilitation requires the knowledge of antineoplastic therapy-induced syndromes, a multimodal treatment plan, and consideration of cancer-related interests on individual patients. The potential for cancer rehabilitation exists in all body systems, and the treating physician should become familiar with its prognosis, expected outcomes, treatment modalities, and predicted functional deterioration (Braddom RL Physical medicine & rehabilitation. Elsevier, Philadelphia, 2016). Long-term sequelae continue to affect survivors due to the variable treatment response and high likelihood of permanent neuromuscular or cognitive deficits.

The purpose of this chapter is to provide readers with the knowledge of expected complications from cancer and its treatments and how to appropriately diagnose and treat these conditions. Vocational rehabilitation and general cancer rehabilitation will be discussed to provide the reader with adequate background to properly direct patient care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Braddom RL. Physical medicine & rehabilitation. Philadelphia: Elsevier; 2016.

    Google Scholar 

  2. Montiero M. Physical therapy implications following the TRAM procedure. Phys Ther. 1997;77:765–70.

    Article  Google Scholar 

  3. Brown H. Anatomy of the spinal accessory nerve plexus: relevance to head and neck cancer and atherosclerosis. Exp Biol Med. 2002;227:570–8.

    Article  CAS  Google Scholar 

  4. McNeely MI, Parlaiment MB, Seikaly H, et al. Effect of exercise on upper extremity pain and dysfunction in head and neck cancer survivors: a randomized controlled trial. Cancer. 2008;113:214–22.

    Article  PubMed  Google Scholar 

  5. Rogers LQ, Anton PM, Fogleman A, et al. Systematic review of the role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ. 2003;327:469.

    Article  Google Scholar 

  6. Happ MB. Interpretation of nonvocal behavior and the meaning of voicelessness in critical care. Soc Sci Med. 2000;50:1247–55.

    Article  CAS  PubMed  Google Scholar 

  7. Abbas JS, et al. The surgical treatment and outcome of soft-tissue sarcoma. Arch Surg. 1981;116:765–9.

    Article  CAS  PubMed  Google Scholar 

  8. Shiu MH, et al. Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg. 1975;182:597–602.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Karakousis CP, Proimakis C, Walsh DL. Primary soft tissue sarcoma of the extremities in adults. Br J Surg. 1995;82:1208–12.

    Article  CAS  PubMed  Google Scholar 

  10. Parsons CM, et al. The role of radical amputations for extremity tumors: a single institution experience and review of the literature. J Surg Oncol. 2012;105:149–55.

    Article  PubMed  Google Scholar 

  11. Whelan JS, et al. Survival from high-grade localized extremity osteosarcoma: combined results and prognostic facts from three European Osteosarcoma Intergroup randomized controlled trials. Ann Oncol. 2011;23:1607–16.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Finn HA, Simon MA. Limb-salvage surgery in the treatment of osteosarcoma in skeletally immature individuals. Orthop Surg Rehab Med. 1991;262:108–18.

    Google Scholar 

  13. Carter SR, et al. Hindquarter amputation for tumors of the musculoskeletal system. J Bone Joint Surg Br. 1990;72:490–3.

    Article  CAS  PubMed  Google Scholar 

  14. Schwarz RE, et al. Long-term survival after radical operations for cancer treatment-induced sarcomas: how two survivors invite reflection on oncologic treatment concepts. Am J Clin Oncol. 2002;25:244–7.

    Article  PubMed  Google Scholar 

  15. McCormick Z, Chang-Chien G, Marshall B, Huang M, Harden RN. Phantom limb pain: a systematic neuroanatomical-based review of pharmacological treatment. Pain Med. 2014;15:292–305.

    Article  PubMed  Google Scholar 

  16. Alviar MJM, Hale T, Dungca M. Pharmacologic interventions for treating phantom limb pain: Review. Cochrane Syst Rev. 2011;12:CD006380.

    Google Scholar 

  17. Nikolajsen L, et al. Randomized trial of epidural bupivacaine and morphine in prevention of stump and phantom pain in lower-extremity limb amputation. Lancet. 1997;350:1353–7.

    Article  CAS  PubMed  Google Scholar 

  18. Soffietti R, Trevisan E, Ruda R. Neurologic complications of chemotherapy and other newer and experimental approaches. Handb Clin Neurol. 2014;121:1199–218.

    Article  PubMed  Google Scholar 

  19. Sioka C, Kryritsis AP. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol. 2009;63:761–7.

    Article  CAS  PubMed  Google Scholar 

  20. Carla C, Verstappen J, Heimans K, et al. Neurotoxin complications of chemotherapy in patients with cancer. Drugs. 2003;63:1549–63.

    Article  Google Scholar 

  21. Chauvenet AR, et al. Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a pediatric oncology group study. J Pediatr Hematol Oncol. 2003;25:316–20.

    Article  PubMed  Google Scholar 

  22. Paulson JC, McClure WO. Inhibition of axoplasmic transport by colchicine, podophyllotoxin, and vinblastine: an effect on microtubules. Ann N Y Acad Sci. 1975;253:517–27.

    Article  CAS  PubMed  Google Scholar 

  23. Sanderson PA, Kuwabara T, Cogan DG. Optic neuropathy presumably caused by vincristine therapy. Am J Ophthalmol. 1976;81:146–50.

    Article  CAS  PubMed  Google Scholar 

  24. Kalcioglu MT, et al. Bilateral hearing loss during vincristine therapy: a case report. J Chemother. 2003;15:290–2.

    Article  CAS  PubMed  Google Scholar 

  25. Moudgil SS, Riggs JE. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy. Ann Pharmacother. 2000;34:1136–8.

    Article  CAS  PubMed  Google Scholar 

  26. Postma TJ, Vermorken JB, Liefting AJ, et al. Paclitaxel-induced neuropathy. Ann Oncol. 1995;6:489–94.

    Article  CAS  PubMed  Google Scholar 

  27. Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012;12:267–75.

    Article  CAS  PubMed  Google Scholar 

  28. Dietrich J, Prust M, Kaiser J. Chemotherapy, cognitive impairment and hippocampal toxicity: Review. Neuroscience. 2015;309:224–32.

    Article  CAS  PubMed  Google Scholar 

  29. Collins B, MacKenzie J, Tasca GA, Scherling C, Smith A. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psychooncology. 2013;22:1517–27.

    Article  PubMed  Google Scholar 

  30. Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist. 2008;13:1285–95.

    Article  PubMed  Google Scholar 

  31. Deng W, Almone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci. 2010;11:339–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Spalding KL, et al. Dynamics of hippocampal neurogenesis in adult humans. Cell. 2013;153:1219–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Seigers R, et al. Inhibition of hippocampal cell proliferation by methotrexate in rats is not potentiated by the presence of a tumor. Brain Res Bull. 2010;81:472–276.

    Article  CAS  PubMed  Google Scholar 

  34. Christie LA, Acharya MM, Parihar VK, Nguyen A, Martirosian V, Limoli CL. Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin Cancer Res. 2012;18:1954–65.

    Article  CAS  PubMed  Google Scholar 

  35. Nokia MS, Anderson ML, Shors TJ. Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain. Eur J Neurosci. 2012;36:3521–30.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Walker EA, Foley JJ, Clark-Vetri R, Raffa RB. Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology. 2011;217:539–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Yang M. Neurotoxicity of methotrexate to hippocampal cells in vivo and in vitro. Biochem Pharmacol. 2011;82:72–80.

    Article  CAS  PubMed  Google Scholar 

  38. De Ruiter MB, et al. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp. 2011;32:1206–19.

    Article  PubMed  Google Scholar 

  39. Higgins AY, O’Halloran TD, Chang JD. Chemotherapy-induced cardiomyopathy. Heart Fail Rev. 2015;20:721–30.

    Article  CAS  PubMed  Google Scholar 

  40. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer. 2003;11:2869–79.

    Article  CAS  Google Scholar 

  41. Todaro MC, et al. Cardioncology: state of the heart. Int J Cardiol. 2013;168:680–7.

    Article  PubMed  Google Scholar 

  42. Seidman A. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol. 2002;20:1215–21.

    Article  CAS  PubMed  Google Scholar 

  43. Khouri MG, et al. Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues. Circulation. 2012;126:2749–63.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Morandi P, et al. Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7g/m(2)) cyclophosphamide. Bone Marrow Transplant. 2002;28:277–82.

    Article  Google Scholar 

  45. Hunt SA, American College of Cardiology F, American Heart A. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation. J Am Coll Cardiol. 2009;53:e1–e90.

    Article  Google Scholar 

  46. Yoon GF, et al. Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies: are clinicians responding optimally? J Am Coll Cardiol. 2010;56:1644–50.

    Article  PubMed  Google Scholar 

  47. Meador M, Floyd J, Perry MC. Pulmonary toxicity of chemotherapy. Semin Oncol. 2006;33:98–105.

    Article  CAS  Google Scholar 

  48. Fennell DA, Rudd RM. Pulmonary toxicity and cancer treatment. Hosp Med. 2004;65:462–4.

    Article  PubMed  Google Scholar 

  49. Sleijfer S. Bleomycin-induced pneumonitis. Chest. 2001;120:617–24.

    Article  CAS  PubMed  Google Scholar 

  50. Kreisman H, Wolkove N. Pulmonary toxicity of antineoplastic therapy. Semin Oncol. 1992;19:508–20.

    CAS  PubMed  Google Scholar 

  51. Rowinsky EK, Donehower RC. Paclitaxel (Taxol). N Engl J Med. 1995;332:1004–14.

    Article  CAS  PubMed  Google Scholar 

  52. O’Meara WP, Thiringer JK, Johnstone PA. Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol. 2003;66:323–6.

    Article  PubMed  Google Scholar 

  53. Tannock IF. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol. 1989;16:83–101.

    Article  CAS  PubMed  Google Scholar 

  54. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown MI. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103:117–28.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Hauer-Jensen M, Fink LM, Wang J. Radiation injury and the protein C pathway. Crit Care Med. 2004;32:S325–30.

    Article  CAS  PubMed  Google Scholar 

  56. Stubblefield MD. Radiation fibrosis syndrome: neuromuscular and musculoskeletal complications in cancer survivors. PMR. 2011;3:1041–54.

    Article  Google Scholar 

  57. Leduc O, Klein P, Demaret P, et al. Dynamic pressure variation under bandages with different stiffness. In: Vascular medicine: proceedings. Amsterdam: Elsevier Science; 1993. p. 465–8.

    Google Scholar 

  58. Liu AK, Macy ME, Foreman NK. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas. Int J Radiat Oncol Biol Phys. 2009;75:1148–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Marks JE, Wong J. The risk of cerebral radionecrosis in relation to dose, time, and fractionation: a follow-up study. Prog Exp Tumor Res. 1985;29:210–8.

    Article  CAS  PubMed  Google Scholar 

  60. Moretti M, Torre P, Antonello RM, et al. Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia. J Neurol Sci. 2005;229–230:195–200.

    Article  PubMed  Google Scholar 

  61. Jr C, Shapiro CL, Ng A, et al. American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25:3991–4008.

    Article  CAS  Google Scholar 

  62. Dropcho EJ. Neurotoxicity of radiation therapy. Neurol Clin. 2010;28:217–324.

    Article  PubMed  Google Scholar 

  63. Libschitz HI, DuBrow RA, Loyer EM, Charnsangavej C. Radiation change in normal organs: an overview of body imaging. Eur Radiol. 1996;6:786–95.

    Google Scholar 

  64. Johansson S, Svensson H, Denekamp J. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys. 2000;48:754–0.

    Article  Google Scholar 

  65. Johansson S, Svensson H, Denekamp J. Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2000;52:1207–19.

    Article  Google Scholar 

  66. Zackrisson B, Mercke C, Strander H, Wennerberg J, Cavalin-Stahl E. A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol. 2003;42:443–61.

    Article  PubMed  Google Scholar 

  67. Fajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol. 2005;44:13–22.

    Article  PubMed  Google Scholar 

  68. Gillette EL, LaRue SM, Gillette SM. Normal tissue tolerance and management of radiation injury. Semin Vet Med Surg. 1995;10:209–13.

    CAS  Google Scholar 

  69. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807–19.

    Article  PubMed  Google Scholar 

  70. Heinricher MM, Tavares I, Leith JL, Lumb BM. Descending control of nociception: specificity, recruitment and plasticity. Brain Res Rev. 2009;60:214–25.

    Article  CAS  PubMed  Google Scholar 

  71. Chan CK, Lee HY, Choi WC, Cho JY, Lee SH. Cervical cord compression presenting with sciatica-like leg pain. Eur Spine J. 2011;20:S217–21.

    Article  PubMed  Google Scholar 

  72. Jaeckle KA. Neurologic manifestations of neoplastic and radiation-induced plexopathies. Semin Neurol. 2010;30:254–62.

    Article  PubMed  Google Scholar 

  73. Hsia AW, Katz JS, Hancock SL, Peterson K. Post-irradiation polyradiculopathy mimics leptomeningeal tumor on MRI. Neurology. 2003;60:1694–6.

    Article  PubMed  Google Scholar 

  74. Miller TM, Layzer RB. Muscle cramps. Muscle Nerve. 2005;32:431–42.

    Article  PubMed  Google Scholar 

  75. Stubblefield MD, Levine A, Custodio CM, Fitzpatrick T. The role of botulinum toxin type A in the radiation fibrosis syndrome: a preliminary report. Arch Phys Med Rehabil. 2008;89:417–21.

    Article  PubMed  Google Scholar 

  76. Shah JP, Danoff JV, Desai MJ, et al. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil. 2008;89:16–23.

    Article  PubMed  Google Scholar 

  77. Engleman MA, Woloschak G, Small W Jr. Radiation-induced skeletal injury. Cancer Treat Res. 2006;128:155–69.

    Article  PubMed  Google Scholar 

  78. Spoudes HA. Growth and endocrine function after chemotherapy and radiotherapy in childhood. Eur J Cancer. 2002;38:1748–59.

    Article  Google Scholar 

  79. Stava CJ, Jimenez C, Hu MI, Vassilopoulou-Sellin R. Skeletal sequelae of cancer and cancer treatment. J Cancer Surviv. 2009;3:75–88.

    Article  PubMed  Google Scholar 

  80. Appels C, Geokoop R. Dropped-head syndrome due to high-dose irradiation. J Rheumatol. 2009;34:666–9.

    Google Scholar 

  81. Rowin J, Cheng G, Lewis SL, Meriggioli MN. Late appearance of dropped-head syndrome after radiotherapy for Hodgkin’s disease. Muscle Nerve. 2006;34:666–9.

    Article  PubMed  Google Scholar 

  82. Stubblefield MD, Burstein HJ, Burton AW, et al. NCCN task force report: management of neuropathy in cancer. J Natl Compr Cancer Netw. 2009;7:S1–S26.

    Article  Google Scholar 

  83. Herrera JE, Stubblefield MD. Rotator cuff tendonitis in lymphedema: a retrospective case series. Arch Phys Med Rehabil. 2004;85:1939–42.

    Article  PubMed  Google Scholar 

  84. Dijkstra PU, Kalk WW, Roodenburg JL. Trismus in head and neck oncology: a systematic review. Oral Oncol. 2004;40:879–89.

    Article  CAS  PubMed  Google Scholar 

  85. Ichimura K, Tanaka T. Trismus in patients with malignant tumours in the head and neck. J Laryngol Otol. 1993;107:1017–20.

    Article  CAS  PubMed  Google Scholar 

  86. Buchbinder D, Currivan RB, Kaplan AJ, Urken ML. Mobilization regimens for the prevention of jaw hypomobility in irradiated patients: an analysis and comparison of two techniques. Med Oral Patol Oral Cir Bucal. 2007;43:389–94.

    Google Scholar 

  87. Huang ME, Cifu DX, Keyser-Marcus L. Functional outcomes after brain tumor and acute stroke: a comparative analysis. Arch Phys Med Rehabil. 1998;79(11):1386–90.

    Article  CAS  PubMed  Google Scholar 

  88. O’Dell MW, Barr K, Spanier D, Warnick RE. Functional outcomes of inpatient rehabilitation in persons with brain tumors. Arch Phys Med Rehabil. 1998;79:1530–4.

    Article  PubMed  Google Scholar 

  89. Cuccurullo SJ. Physical medicine and rehabilitation board review. 3rd ed. New York: Demos Medical; 2014.

    Google Scholar 

  90. Casley-Smith JR. The pathophysiology of lymphedema and the action of benzopyrones in reducing it. Lymphology. 1988;21:190–4.

    CAS  PubMed  Google Scholar 

  91. Casley-Smith JR. Modern treatment for lymphedema. 5th ed. Malvern: The Lymphoedema Association of Australia Inc; 1997.

    Google Scholar 

  92. Wood TJ, Racano A, Yeung H, et al. Surgical management of bone metastases: quality of evidence and systematic review. Ann Surg Oncol. 2014;21:4081–9.

    Article  PubMed  Google Scholar 

  93. McKinley WO, Huang ME, Tewksbury MA. Neoplastic vs. traumatic spinal cord injury: an inpatient rehabilitation comparison. Am J Phys Phys Med Rehabil. 2000;79:138–44.

    Article  CAS  Google Scholar 

  94. Silver JK. Cancer rehabilitation and prehabilitation may reduce disability and early retirement. Cancer. 2014;120:2072–6.

    Article  PubMed  Google Scholar 

  95. Huang GH, Ismail H, Murnane A, Kim P, Riedel B. Structures exercise program prior to major cancer surgery improves cardiopulmonary fitness: a retrospective cohort study. Support Care Cancer. 2016;24(5):2277–85. Epub 2015 Nov 21

    Article  PubMed  Google Scholar 

  96. Tsimopoulou I, Pasquali S, Howard R, Dasai A, Gourevitch D, Tolosa I, Vohra R. Psychological prehabilitation before cancer surgery: a systematic review. Ann Surg Oncol. 2015;22(13):4117–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Texas Health Science Center at San Antonio (UTHSCSA), UT Medicine Pain Consultants, Department of Anesthesiology, San Antonio, TX, USA

    Ameet Nagpal, Maxim S. Eckmann & Brian Boies

  2. University of Texas Health Science Center at San Antonio (UTHSCSA), Department of Anesthesiology, San Antonio, TX, USA

    Ameet Nagpal, Maxim S. Eckmann & Brian Boies

  3. Kansas City VA Medical Center, Kansas City, MO, USA

    Jacob Fehl

  4. University of Texas Health Science Center at San Antonio (UTHSCSA), Department of Physical Medicine and Rehabilitation, San Antonio, TX, USA

    Brittany Bickelhaupt

  5. South Texas Spinal Clinic, San Antonio, TX, USA

    Jon Benfield

Authors
  1. Ameet Nagpal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacob Fehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brittany Bickelhaupt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maxim S. Eckmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Brian Boies
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jon Benfield
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ameet Nagpal .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology and Critical Care, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Amitabh Gulati

  2. Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Vinay Puttanniah

  3. Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX, USA

    Brian M. Bruel

  4. Midwest Neuroscience Institute, Center for the Relief of Pain, Kansas City, MO, USA

    William S. Rosenberg

  5. Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Joseph C. Hung

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nagpal, A., Fehl, J., Bickelhaupt, B., Eckmann, M.S., Boies, B., Benfield, J. (2019). Cancer Rehabilitation. In: Gulati, A., Puttanniah, V., Bruel, B., Rosenberg, W., Hung, J. (eds) Essentials of Interventional Cancer Pain Management. Springer, Cham. https://doi.org/10.1007/978-3-319-99684-4_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-99684-4_40

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-99682-0

  • Online ISBN: 978-3-319-99684-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation